Showing results (231-240 of 880) with videos related to

Sort By:
Pageof 88
Alimentary Pharmacology & Therapeutics|March 11, 2022
Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel diseaseMohammad Zamani, Shaghayegh Alizadeh-Tabari, Siddharth Singh, et al.
The American Journal of Gastroenterology|June 6, 2018
Obesity and Response to Infliximab in Patients with Inflammatory Bowel Diseases: Pooled Analysis of Individual Participant Data from Clinical TrialsSiddharth Singh, James Proudfoot, Ronghui Xu, et al.
BMJ Case Reports|May 31, 2014
Mistaken identity: normotensive scleroderma renal crisisArwa Aburizik, Siddharth Singh, Laith Al-Rabadi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 8, 2022
Inflammatory Bowel Disease Is Associated With an Increased Risk of Incident Acute Arterial Events: Analysis of the United Kingdom BiobankQuazim A Alayo, Edward V Loftus, Andres Yarur, et al.
Inflammatory Bowel Diseases|September 23, 2022
Osteonecrosis in Inflammatory Bowel Disease: Clinical Features, Risk Factor Analysis, and OutcomesZeinab Bakhshi, Siddhant Yadav, W Scott Harmsen, et al.
Inflammatory Bowel Diseases|August 5, 2004
Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control studyElena Ricart, Remo Panaccione, Edward V Loftus, et al.
Inflammatory Bowel Diseases|January 9, 2007
Symptomatic overlap between irritable bowel syndrome and microscopic colitisDavid Limsui, Darrell S Pardi, Michael Camilleri, et al.
Inflammatory Bowel Diseases|March 29, 2013
Risk factors for lymphoma in patients with inflammatory bowel disease: a case-control studyWaqqas Afif, William J Sandborn, William A Faubion, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 14, 2011
Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trialRemo Panaccione, Edward V Loftus, David Binion, et al.
Inflammatory Bowel Diseases|April 30, 2002
Delayed hypersensitivity reaction and acute respiratory distress syndrome following infliximab infusionDouglas L Riegert-Johnson, John A Godfrey, Jeffrey L Myers, et al.
Pageof 88